QiQi
End of January fits pretty well with the timeline on page 7 - interim is placed early 2018.
SP recovery depends on the trial data - there's news coming for mimotope and arginine, but it's the gastro info that's going to have the biggest impact in the next few months.
If the EPD is mediocre (or worse) it could get ugly, but that's followed by announcements for mimotope and arginine that could provide a couple of bumps before returning to the 'is it good or bad?' attached to the interim. Three lines of news and uncertainty surrounding the trial. I think you're right, it's looking good for traders.
dyor etc etc etc
Cheers
Ann: Trading Halt, page-107
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
-0.001(1.96%) |
Mkt cap ! $365.9M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.2¢ | 4.9¢ | $896.1K | 17.89M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 5978561 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 299041 | 4 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |